Adaptation of synthetic peptide substrate-based assays on a discrete analyzer.
D000990:Antithrombin III / Q000008:administration & dosage / Q000032:analysis; D001322:Autoanalysis; D001778:Blood Coagulation Disorders / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy; D001780:Blood Coagulation Tests / Q000295:instrumentation* / Q000379:methods; D001803:Blood Transfusion; D002138:Calibration; D002863:Chromogenic Compounds; D005170:Factor X / Q000032:analysis; D005343:Fibrinolytic Agents / Q000008:administration & dosage; D006493:Heparin / Q000008:administration & dosage / Q000097:blood; D006801:Humans; D010958:Plasminogen / Q000032:analysis; D000979:alpha-2-Antiplasmin / Q000032:analysis
D002863:Chromogenic Compounds; D005343:Fibrinolytic Agents; D000979:alpha-2-Antiplasmin; D000990:Antithrombin III; D005170:Factor X; D010958:Plasminogen; D006493:Heparin